PharmaBlock Sciences Nanjing Inc Class A Cash Flow Reinvestment Rate
PharmaBlock Sciences Nanjing Inc Class A cash flow reinvestment rate. PharmaBlock Sciences Nanjing Inc Class A (300725) has a Cash Flow Reinvestment Rate of 0.05x as of September 2025, reinvesting CN¥4.24 Million (capex CN¥4.24 Million ) from operating cash flow of CN¥83.36 Million. Explore cash flow to debt ratio of PharmaBlock Sciences Nanjing Inc Class A to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of PharmaBlock Sciences Nanjing Inc Class A (2013–2025)
Cash flow reinvestment rate of PharmaBlock Sciences Nanjing Inc Class A from 2013 to 2025. Historical reinvestment intensity for PharmaBlock Sciences Nanjing Inc Class A across 13 annual periods. Explore PharmaBlock Sciences Nanjing Inc Class A capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
PharmaBlock Sciences Nanjing Inc Class A Cash Flow Reinvestment Rate by Year (2013–2025)
PharmaBlock Sciences Nanjing Inc Class A cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for PharmaBlock Sciences Nanjing Inc Class A. For the full cash flow conversion analysis, see cash flow conversion of PharmaBlock Sciences Nanjing Inc Class A.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥180.08 Million | CN¥667.36 Million | CN¥140.13 Million | ▼ -52.3% |
| 2024 | 0.57x | CN¥171.27 Million | CN¥302.82 Million | CN¥118.12 Million | ▼ -88.9% |
| 2023 | 5.10x | CN¥1.26 Billion | CN¥246.84 Million | CN¥315.77 Million | ▲ +9.3% |
| 2022 | 4.67x | CN¥1.15 Billion | CN¥246.61 Million | CN¥557.91 Million | ▲ +42.2% |
| 2021 | 3.28x | CN¥781.90 Million | CN¥238.03 Million | CN¥505.76 Million | ▲ +507.6% |
| 2020 | 0.54x | CN¥146.78 Million | CN¥271.51 Million | CN¥75.18 Million | ▼ -76.4% |
| 2019 | 2.29x | CN¥290.56 Million | CN¥127.04 Million | CN¥173.52 Million | ▲ +599.6% |
| 2018 | 0.33x | CN¥52.36 Million | CN¥160.16 Million | CN¥48.44 Million | ▼ -88.8% |
| 2017 | 2.91x | CN¥159.06 Million | CN¥54.64 Million | CN¥49.06 Million | ▼ -32.0% |
| 2016 | 4.28x | CN¥97.36 Million | CN¥22.76 Million | CN¥38.26 Million | ▲ +1113.5% |
| 2015 | 0.35x | CN¥9.70 Million | CN¥27.52 Million | CN¥9.70 Million | ▼ -55.7% |
| 2014 | 0.80x | CN¥9.48 Million | CN¥11.91 Million | CN¥9.48 Million | ▲ +133.9% |
| 2013 | 0.34x | CN¥6.23 Million | CN¥18.32 Million | CN¥6.23 Million | — |